Gene · 55
Papers3,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 3,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches. | Front Oncol | 2017 | 28459041 | PubTator, text mining | PubMed |
| Bispecific protein targets prostate cancer. | Oncotarget | 2017 | 28455964 | PubTator, text mining | PubMed |
| Suspected tumor-to-meningioma metastasis: A case report. | Oncol Lett | 2017 | 28454286 | PubTator, text mining | PubMed |
| Acyl Carrier Protein Cyanylation Delivers a Ketoacyl Synthase-Carrier Protein Cross-Link. | Biochemistry | 2017 | 28448715 | PubTator, text mining | PubMed |
| TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells. | Oncotarget | 2017 | 28445989 | PubTator, text mining | PubMed |
| Immunotherapy in genitourinary malignancies. | J Hematol Oncol | 2017 | 28434403 | PubTator, text mining | PubMed |
| Inhibition effects of chlorogenic acid on benign prostatic hyperplasia in mice. | Eur J Pharmacol | 2017 | 28416373 | PubTator, text mining | PubMed |
| Quercetin Remodels the Tumor Microenvironment To Improve the Permeation, Retention, and Antitumor Effects of Nanoparticles. | ACS Nano | 2017 | 28414916 | PubTator, text mining | PubMed |
| Proof-of-Concept Workflow for Establishing Reference Intervals of Human Urine Proteome for Monitoring Physiological and Pathological Changes. | EBioMedicine | 2017 | 28396014 | PubTator, text mining | PubMed |
| Emerging proteomics biomarkers and prostate cancer burden in Africa. | Oncotarget | 2017 | 28388542 | PubTator, text mining | PubMed |
| Role of Antigen Spread and Distinctive Characteristics of Immunotherapy in Cancer Treatment. | J Natl Cancer Inst | 2017 | 28376158 | PubTator, text mining | PubMed |
| Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy? | Angiogenesis | 2017 | 28361267 | PubTator, text mining | PubMed |
| Emerging Variants of Castration-Resistant Prostate Cancer. | Curr Oncol Rep | 2017 | 28361223 | PubTator, text mining | PubMed |
| Phase I clinical trial of sipuleucel-T combined with escalating doses of ipilimumab in progressive metastatic castrate-resistant prostate cancer. | Immunotargets Ther | 2017 | 28361045 | PubTator, text mining | PubMed |
| Horizontal alignment of 5' -> 3' intergene distance segment tropy with respect to the gene as the conserved basis for DNA transcription. | Future Sci OA | 2017 | 28344824 | PubTator, text mining | PubMed |
| Epigallocatechin Gallate Inhibits Macaque SEVI-Mediated Enhancement of SIV or SHIV Infection. | J Acquir Immune Defic Syndr | 2017 | 28328549 | PubTator, text mining | PubMed |
| Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines. | Pharmacol Ther | 2017 | 28322974 | PubTator, text mining | PubMed |
| The role of IL-7 in Immunity and Cancer. | Anticancer Res | 2017 | 28314253 | PubTator, text mining | PubMed |
| Brazilin Inhibits Prostatic Acidic Phosphatase Fibrillogenesis and Decreases its Cytotoxicity. | Chem Asian J | 2017 | 28303660 | PubTator, text mining | PubMed |
| Cancer Targeting Potential of 99mTc-Finasteride in Experimental Model of Prostate Carcinogenesis. | Cancer Biother Radiopharm | 2017 | 28301260 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55/papers?page=57